Market Overview

Oppenheimer Initiates Coverage on Quest Diagnostics Incorporated at Underperform, Announces $53.00 undefined

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for DGX

DateFirmActionFromTo
Nov 2014Deutsche BankUpgradesHoldBuy
Jul 2014Canaccord GenuityMaintainsHold
Jul 2014CitigroupMaintainsNeutral

View More Analyst Ratings for DGX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (DGX)

Around the Web, We're Loving...

Get Benzinga's Newsletters